CAR- T and also mobile gene treatments are actually too costly
.Mother Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and modern technology transfer may supply cellular genetics therapies at a budget friendly expense to clients across the world.